Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
121.80
-1.73 (-1.40%)
May 5, 2025, 4:00 PM EDT - Market closed

Biogen Statistics

Total Valuation

Biogen has a market cap or net worth of $17.85 billion. The enterprise value is $21.87 billion.

Market Cap 17.85B
Enterprise Value 21.87B

Important Dates

The last earnings date was Thursday, May 1, 2025, before market open.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

Biogen has 146.53 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class 146.53M
Shares Outstanding 146.53M
Shares Change (YoY) +0.21%
Shares Change (QoQ) +0.34%
Owned by Insiders (%) 0.16%
Owned by Institutions (%) 91.17%
Float 146.15M

Valuation Ratios

The trailing PE ratio is 12.04 and the forward PE ratio is 7.79. Biogen's PEG ratio is 2.78.

PE Ratio 12.04
Forward PE 7.79
PS Ratio 1.81
Forward PS 1.92
PB Ratio 1.05
P/TBV Ratio 19.46
P/FCF Ratio 7.32
P/OCF Ratio 6.91
PEG Ratio 2.78
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.10, with an EV/FCF ratio of 8.98.

EV / Earnings 14.78
EV / Sales 2.23
EV / EBITDA 7.10
EV / EBIT 9.22
EV / FCF 8.98

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.39.

Current Ratio 1.44
Quick Ratio 0.87
Debt / Equity 0.39
Debt / EBITDA 2.07
Debt / FCF 2.72
Interest Coverage 9.84

Financial Efficiency

Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 6.48%.

Return on Equity (ROE) 9.19%
Return on Assets (ROA) 5.43%
Return on Invested Capital (ROIC) 6.48%
Return on Capital Employed (ROCE) 10.43%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.36
Inventory Turnover 1.00

Taxes

In the past 12 months, Biogen has paid $273.10 million in taxes.

Income Tax 273.10M
Effective Tax Rate 15.58%

Stock Price Statistics

The stock price has decreased by -44.00% in the last 52 weeks. The beta is 0.12, so Biogen's price volatility has been lower than the market average.

Beta (5Y) 0.12
52-Week Price Change -44.00%
50-Day Moving Average 131.65
200-Day Moving Average 164.54
Relative Strength Index (RSI) 46.53
Average Volume (20 Days) 1,722,585

Short Selling Information

The latest short interest is 3.45 million, so 2.35% of the outstanding shares have been sold short.

Short Interest 3.45M
Short Previous Month 3.34M
Short % of Shares Out 2.35%
Short % of Float 2.36%
Short Ratio (days to cover) 1.87

Income Statement

In the last 12 months, Biogen had revenue of $9.82 billion and earned $1.48 billion in profits. Earnings per share was $10.12.

Revenue 9.82B
Gross Profit 7.43B
Operating Income 2.37B
Pretax Income n/a
Net Income 1.48B
EBITDA 3.08B
EBIT 2.37B
Earnings Per Share (EPS) $10.12
Full Income Statement

Balance Sheet

The company has $2.60 billion in cash and $6.62 billion in debt, giving a net cash position of -$4.02 billion or -$27.45 per share.

Cash & Cash Equivalents 2.60B
Total Debt 6.62B
Net Cash -4.02B
Net Cash Per Share -$27.45
Equity (Book Value) 16.98B
Book Value Per Share 115.90
Working Capital 2.33B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $2.58 billion and capital expenditures -$144.90 million, giving a free cash flow of $2.44 billion.

Operating Cash Flow 2.58B
Capital Expenditures -144.90M
Free Cash Flow 2.44B
FCF Per Share $16.63
Full Cash Flow Statement

Margins

Gross margin is 75.65%, with operating and profit margins of 24.16% and 15.07%.

Gross Margin 75.65%
Operating Margin 24.16%
Pretax Margin 17.85%
Profit Margin 15.07%
EBITDA Margin 31.39%
EBIT Margin 24.16%
FCF Margin 24.82%

Dividends & Yields

Biogen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.21%
Shareholder Yield -0.21%
Earnings Yield 8.29%
FCF Yield 13.65%
Dividend Details

Analyst Forecast

The average price target for Biogen is $202.91, which is 66.59% higher than the current price. The consensus rating is "Buy".

Price Target $202.91
Price Target Difference 66.59%
Analyst Consensus Buy
Analyst Count 27
Revenue Growth Forecast (5Y) 0.03%
EPS Growth Forecast (5Y) 10.16%
Stock Forecasts

Stock Splits

The last stock split was on January 18, 2001. It was a forward split with a ratio of 3:1.

Last Split Date Jan 18, 2001
Split Type Forward
Split Ratio 3:1

Scores

Biogen has an Altman Z-Score of 3.17 and a Piotroski F-Score of 6.

Altman Z-Score 3.17
Piotroski F-Score 6